Prospect Financial Services’s Acurx Pharmaceuticals ACXP Stock Holding History

Prospect Financial Services’s Portfolio ACXP Stock Details ACXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.4K	Hold	13,785	–	–	0.01%	115
2026 Q1	$51.1K	Sell	13,785 -6,048	-30%	-$17.2K	0.03%	104
2025 Q4	$49.4K	Sell	19,833 -50	-0.3%	-$240	0.03%	104
2025 Q3	$85.3K	Buy	19,883 +5,044	+34%	+$30.4K	0.05%	104
2025 Q2	$152K	Sell	14,839 -3,490	-19%	-$28.1K	0.09%	100
2025 Q1	$143K	Buy	18,329 +1,875	+11%	+$25.3K	0.08%	108
2024 Q4	$268K	Buy	16,454 +1,700	+12%	+$51.2K	0.15%	92
2024 Q3	$561K	Buy	14,754 +849	+6%	+$35.9K	0.35%	47
2024 Q2	$626K	Buy	13,905 +262	+2%	+$11.5K	0.48%	40
2024 Q1	$668K	Buy	13,643 +885	+7%	+$57.5K	0.55%	39
2023 Q4	$977K	Buy	+12,758	New	+$963K	0.99%	24

Other funds holding ACXP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Prospect Financial Services's ACXP Position: Q2 2026 in Review

Prospect Financial Services held its Acurx Pharmaceuticals (ACXP) position steady in Q2 2026 at 13,785 shares worth $21.4K. The position accounts for 0.01% of the portfolio, ranked #115.

Prospect Financial Services first reported a position in ACXP in Q4 2023 and has held it in 11 quarters since. The position peaked at $977K in Q4 2023. 19 funds tracked by Wall St. Rank hold ACXP as of Q2 2026.

Prospect Financial Services held 13,785 shares of Acurx Pharmaceuticals worth $21.4K as of Q2 2026.
Prospect Financial Services left its Acurx Pharmaceuticals share count unchanged in Q2 2026.
Acurx Pharmaceuticals made up 0.01% of Prospect Financial Services's portfolio in Q2 2026, its #115 holding.
Prospect Financial Services first reported a position in Acurx Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Prospect Financial Services's Acurx Pharmaceuticals position peaked at $977K in Q4 2023.
19 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q2 2026.

Based on Prospect Financial Services's 13F filing for Q2 2026, filed 6 Aug 2026.